HOME >> MEDICINE >> NEWS
Study finds fewer than half of early stage breast cancer patients get full chemotherapy doses

Data being published in the Journal of Clinical Oncology point to an alarming pattern in breast cancer treatment -- less than half of women with early stage breast cancer whose records were evaluated received their full, recommended dose of potentially life-saving chemotherapy. Researchers found that 56 percent of 20,799 women treated for early stage breast cancer nationwide received less than 85 percent of their prescribed chemotherapy dose intensity due to treatment delays or dose reductions.

Data from a new study published in today's Journal of Clinical Oncology points to an alarming pattern in breast cancer treatment -- less than half of women with early stage breast cancer whose records were evaluated received their full, recommended dose of potentially life-saving chemotherapy.

Researchers from the University of Rochester's James P. Wilmot Cancer Center conducted a comprehensive retrospective analysis and found that 56 percent of the 20,799 women treated for early stage breast cancer in 1,243 community-based oncology practices nationwide received less than 85 percent of their prescribed chemotherapy dose intensity due to treatment delays or dose reductions.

In 25 percent of the cases, patients saw treatment delays of more than a week and 37 percent had chemotherapy dose reductions due to common side effects of treatment, says Gary H. Lyman, M.D., M.P.H., lead author of the study and director of the health services and outcomes research program at the Wilmot Cancer Center.

Previous studies have demonstrated that receiving less than 85 percent of the recommended dose intensity can result in lower survival rates for women with breast cancer.

The primary cause of chemotherapy delays and dose reductions is neutropenia, a shortage of infection-fighting white blood cells. This is a common, potentially serious side effect of chemotherapy.

Chemotherapy drugs are designed to destroy cancer cells,
'"/>

Contact: Leslie White
leslie_white@urmc.rochester.edu
585-273-1119
University of Rochester Medical Center
14-Dec-2003


Page: 1 2 3

Related medicine news :

1. Study of energy and health in Africa focuses spotlight on charcoal and forest management
2. Study shows promise in identifying kidney failure
3. Study shows patch therapy may be as effective as oral medications
4. Study shows soy is well accepted in school lunches
5. Study finds that coordinating care of chronically ill patients does not increase liability
6. Study provides new estimates of the causes of child mortality worldwide
7. Study finds factors linked to substance use disorder relapse among health care professionals
8. Study finds majority of women willing to accept cervical cancer vaccine for self and children
9. Study shows use of budesonide reduced the risk of asthma related events by 40% in children
10. Study shows risk of cardiac death after radiation for breast cancer has dramatically decreased
11. Study shows acrylamide in baked and fried food does not increase risk of breast cancer in women

Post Your Comments:
(Date:5/23/2013)... 2013 911 Signal USA is attending the ... on May 22 and run through May 24, 2013. , ... the company's emergency vehicle lights and sirens, 911 ... Charger at the expo. , The Charger has been equipped ... and can be seen by visiting 911 Signal USA during ...
(Date:5/22/2013)... (PRWEB) May 22, 2013 The surging ... consumers, however cutting through marketing claims to compare mattresses ... The Sleepy Shopper, a bed blog , offers shoppers ... leading types in their latest article. , Titled “ ... ”, this article guides readers through the basics of ...
(Date:5/22/2013)... Singapore (PRWEB) May 23, 2013 The Yoga of ... who lived a thousand years ago. This is the oldest ... leaves). , Lady Niguma was the partner of renowned Indian ... first known series specifically designed by a female yoga master. ... who in turn passed it on through a long lineage to ...
(Date:5/22/2013)... May 22, 2013 Jury deliberations are now ... involving a da Vinci lawsuit, Bernstein Liebhard LLP ... of a man who allegedly died of da Vinci surgery ... million in damages from Intuitive Surgical, Inc. Among other ... program for the da Vinci Surgical System in its efforts ...
(Date:5/22/2013)... Amy Norton HealthDay Reporter , , WEDNESDAY, May ... with athlete,s foot knows there is something about feet ... the first detailed "map" of the fungal groups that ... feet are the hottest neighborhood. It,s no secret ... such as bacteria, viruses and fungi, both outside and ...
Breaking Medicine News(10 mins):Health News:911 Signal USA Attends the 2013 Southwest Police Fleet Expo 2Health News:Mattress Comparison Overview Released by The Sleepy Shopper; Compares Top Types and Brands 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 2Health News:Popular Yoga DVD, Lady Niguma Yoga Released for Sale Online 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 2Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 3Health News:Da Vinci Robot Lawsuits: Bernstein Liebhard LLP Notes Beginning of Jury Deliberations in Nation’s First Trial Involving Alleged Da Vinci Surgery Complications 4Health News:Scientists Map the Fungi on Your Feet 2Health News:Scientists Map the Fungi on Your Feet 3
(Date:5/22/2013)... OREM, Utah , May 22, 2013  Aribex, ... handheld X-ray system, today introduced a new color option, ... into the U.S. dental and veterinary markets. The popular ... released last month will continue to be available and ... equipment dealers. (Photo: http://photos.prnewswire.com/prnh/20130522/CL19573 ) ...
(Date:5/22/2013)... Conn. , May 22, 2013 /PRNewswire-iReach/ -- ... stay aligned with the latest trends and events, ... that can predict where an industry is headed ... evolve. (Photo: http://photos.prnewswire.com/prnh/20130522/CG19099 ) ... partnership with market research publisher GlobalData, offer decision ...
(Date:5/22/2013)... 22, 2013  The Leukemia & Lymphoma Society (LLS) ... Biotherapeutics, LLC, a joint venture between ImmunGene and Caliber, ... a Phase I clinical trial for a novel fusion ... many patients with indolent lymphomas who do not respond ... protein, IGN002, is a new class of biotherapeutics produced ...
Breaking Medicine Technology:Aribex Unveils New Color of NOMAD Pro 2 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 2Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 3Adapt, React, Evolve: Staying Ahead in the Breast Cancer Gene Testing, Solar Energy, and Oil & Gas Markets with Reliable Analytics and Actionable Insights from GlobalData's 700 Market Analysts 4The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 2The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 3The Leukemia & Lymphoma Society, Valor Biotherapeutics and ImmunGene Create Partnership to Advance Novel Therapy for Non-Hodgkin Lymphoma Patients 4
Cached News: